In LSCC, we ascertained that expression of KRT17 in a panel of LSCC samples (42 cases) was positively correlated with the differentiation, T-typing, lymph node metastasis, and clinical stage. This evidence concerns the gene KRT17 and metastatic malignant neoplasm in the lymph nodes.